Trial intelligence / Profile preview

EVICEL for suture-line sealing in paediatric cranial neurosurgery

2013-003558-26Phase 3Unknown

Sponsor
Ethicon
Start
May 2014
Modality
Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised trial of porcine fibrin sealant in cerebrospinal fluid leak and Conditions requiring cranial neurosurgical procedures (2 arms), sponsored by Ethicon. Primary endpoint: Intraoperative watertight dural closure success. Status: unknown.

02

Drugs

porcine fibrin sealant
03

Conditions

cerebrospinal fluid leakConditions requiring cranial neurosurgical procedures

Beyond the preview

Go deeper on 2013-003558-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003558-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call